Download PDF
CC BY-NC-ND 4.0 · World J Nucl Med 2022; 21(01): 076-079
DOI: 10.1055/s-0042-1748155
Case Report

Carcinoma Penis Manifesting as Upfront Supraclavicular Lymph Node Metastases Detected by 18F-Fluorodeoxyglucose Positron Emission Tomography Scan: Report of an Extremely Rare and Aggressive Case

Abhishek Purkayastha
1   Department of Radiation Oncology, Command Hospital (Southern Command), Pune, Maharashtra, India
,
Virender Suhag
1   Department of Radiation Oncology, Command Hospital (Southern Command), Pune, Maharashtra, India
,
Sachin Taneja
1   Department of Radiation Oncology, Command Hospital (Southern Command), Pune, Maharashtra, India
,
Azhar Husain
2   Department of Nuclear Medicine, Command Hospital (Southern Command), Pune, Maharashtra, India
› Author Affiliations Funding None.
› Further Information
Also available at
   Permissions and Reprints

Abstract

Carcinoma penis is a rare malignancy accounting 0.5 to 1% cases in the developed countries with a slightly higher incidence in the developing nations. Slow locoregional progression is characteristic of penile carcinoma and distant metastases are very uncommon. We hereby report a case of highly aggressive squamous cell penile carcinoma in a 46-year-old male with fulminant upfront distant dissemination to left supraclavicular lymph nodes without involving the inguinal and pelvic nodes detected by whole-body 18F-fluorodeoxyglucose positron emission tomography scan. The scan also detected lytic destructive lesion involving the pelvic and adjacent bones with infiltration of skeletal muscles. He was treated with palliative radiotherapy to the weight-bearing sites followed by systemic chemotherapy. A thorough review of literature reveals that our case may be one of the rarest cases ever reported in world literature where an asymptomatic penile carcinoma presents with upfront supraclavicular lymph node metastasis bypassing the inguinal, pelvic, and retroperitoneal lymph node chains.

Keywords

carcinoma penis - metastases - supraclavicular lymph nodes - 18F-fluorodeoxyglucose positron emission tomography scan

Authors' Contribution

Purkayastha Abhishek conceptualized, designed and prepared the manuscript. Purkayastha Abhishek and Suhag Virender were involved in definition of intellectual content and literature search. Purkayastha Abhishek, Suhag Virender, and Taneja Sachin contributed substantially in clinical studies, data analysis, and statistical analysis. Purkayastha Abhishek, Suhag Virender, and Husain Azhar helped in data acquisition. Purkayastha Abhishek, Suhag Virender, Taneja Sachin, and Husain Azhar were involved in manuscript editing and review. Purkayastha Abhishek, Suhag Virender, Taneja Sachin, and Husain Azhar provided guarantee. The manuscript has been read and approved by all the authors, the requirements for authorship have been met, and each author believes that the manuscript represents honest work.


Ethical Approval

Written informed consent to publication was obtained from the patient.




Publication History

Article published online:
30 April 2022

© 2022. World Association of Radiopharmaceutical and Molecular Therapy (WARMTH). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Braumann L, Tsagozis P, Wedin R, Brosjö O. Femoral metastasis from penile carcinoma: report of 2 cases. Case Rep Urol 2015; 2015: 583851
    PubMedGoogle Scholar
  • 2 Banzo J, Ubieto MA, Andrés A. et al. The contribution of 18F-FDG PET/CT in a patient with cutaneous metastases of squamous cell carcinoma of the penis. Rev Esp Med Nucl Imagen Mol 2014; 33 (05) 293-295
    PubMedGoogle Scholar
  • 3 Zhu Y, Ye DW. Lymph node metastases and prognosis in penile cancer. Chin J Cancer Res 2012; 24 (02) 90-96
    CrossrefPubMedGoogle Scholar
  • 4 Oukessou Y, Hammouda Y, El Bouhmadi K, Abada RL, Roubal M, Mahtar M. Supraclavicular lymph node metastases from distant primary tumors: case reports and review of the literature. Int J Surg Case Rep 2021; 81: 105720
    CrossrefPubMedGoogle Scholar
  • 5 Ottenhof SR, Vegt E. The role of PET/CT imaging in penile cancer. Transl Androl Urol 2017; 6 (05) 833-838
    CrossrefPubMedGoogle Scholar
  • 6 Marchionne E, Perez C, Hui A, Khachemoune A. Penile squamous cell carcinoma: a review of the literature and case report treated with Mohs micrographic surgery. An Bras Dermatol 2017; 92 (01) 95-99
    CrossrefPubMedGoogle Scholar
  • 7 Lopes A, Bezerra AL, Pinto CA, Serrano SV, de MellO CA, Villa LL. p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy. J Urol 2002; 168 (01) 81-86
    CrossrefPubMedGoogle Scholar
  • 8 Raja V, Subramaniam C, Prasad BR, Kumar ML, Raj BV. Are all left supraclavicular lymphadenopathies Virchow's? A retrospective study of 320 left cervical lymphadenopathy. Clin Cancer Investig J 2016; 5: 15-19
    Google Scholar
  • 9 Saifullah MK, Sutradhar SR, Khan NA. et al. Diagnostic evaluation of supraclavicular lymphadenopathy. Mymensingh Med J 2013; 22 (01) 8-14
    PubMedGoogle Scholar
  • 10 Zhang S, Li W, Liang F. Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in penile cancer. Oncotarget 2016; 7 (30) 48600-48606
    CrossrefPubMedGoogle Scholar